{
  "docId": "019de072-95ca-731a-9896-42747d7adc13",
  "docSlug": "33535989d43f8c82917f7de34c9c9d29",
  "documentTitle": "AbCellera | Investor Conference Presentation Deck | 25 slides",
  "authorId": "abcellera",
  "authorName": "AbCellera",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 19,
  "pageCount": 25,
  "prevPage": 18,
  "nextPage": 20,
  "slideType": "other",
  "function": "establish_context",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide highlights three specific acquisitions (OrthoMab, Trianni, TetraGenetics) and their role in enabling T cell engagers and GPCR/ion channel research.",
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de072-95ca-731a-9896-42747d7adc13/19",
  "deckHref": "/decks/019de072-95ca-731a-9896-42747d7adc13",
  "deckJsonHref": "/decks/019de072-95ca-731a-9896-42747d7adc13.json",
  "deckAnchorHref": "/decks/019de072-95ca-731a-9896-42747d7adc13#slide-19",
  "components": [
    {
      "bbox": {
        "h": 0.5,
        "w": 0.3,
        "x": 0.45,
        "y": 0.25
      },
      "kind": "image",
      "text": "Visual representation of T cell engagers and GPCR/ion channels",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "644087e5-74d5-400f-9a74-4f082bef53d7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.15,
        "x": 0.8,
        "y": 0.25
      },
      "kind": "list",
      "text": "Enabled by the following acquisitions: OrthoMab Bispecific Platform (2020), TRIANNI (2020), TetraGenetics (2021)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "098358dd-60ff-4a25-8275-63beca2171d9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.3,
        "x": 0.09,
        "y": 0.55
      },
      "kind": "paragraph",
      "text": "Recent acquisitions successfully integrated into our tech stack are being leveraged to unlock new programs.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0777b460-bf56-4c55-9fd3-8d5040186860",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.35,
        "x": 0.09,
        "y": 0.23
      },
      "kind": "title",
      "text": "UNLOCKING NEW DRUG CLASSES WITH TECH",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a43e0934-eb70-4891-b50e-1e0bd1f93a1b",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 25,
      "from": 15,
      "beatId": "023a0501-0c03-4e63-bedc-a8990b45e091",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Impact & Next Steps",
      "beatSlug": "consultants-gambit-impact-next-steps",
      "evidence": "Slides 15-25 outline the forward integration, revenue profile, and key value drivers.",
      "position": 4,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}